Study Stopped
Business Decision
Managing Wounds With Allevyn Life in a Home Health Care Environment
A Randomized, Controlled Study of Allevyn Life in the Management of Wounds in Home Health Care
1 other identifier
interventional
N/A
1 country
3
Brief Summary
When elderly patients need help caring for wounds, physicians may refer patients to home health care providers. The home health provider sees the patient in the patient's home and assists the patient with wound care. Working with the patient's physician, the home health provider will use the appropriate wound covering ("dressing" or "bandage") to cover the wound. The goal of the home health provider is to ensure that the wound stays clean and progresses toward closure. The home health provider will conduct in-home patient visits at appropriate intervals to assess the status of the wound. Extensive resources are required to see patients in their own homes. If a dressing could effectively manage wounds and allow longer time between in-home visits (without affecting patient safety or progress of the wound toward closure), then resources could be saved. Thus, newer dressings are designed for longer wear times, using advanced foam pads and adhesives that help keep the dressing in place. The hypothesis of this study is that the use of Allevyn Life will decrease the number of in-home visits by home health providers without sacrificing patient safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2016
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2016
CompletedFirst Posted
Study publicly available on registry
May 18, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedFebruary 9, 2017
February 1, 2017
11 months
May 16, 2016
February 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of home health clinician visits in each group
60 days
Secondary Outcomes (5)
Home health provider time on-site
60 days
Total cost of each treatment group
60 days
Number of visits required compared to number initially anticipated
60 days
Assess the Cardiff Wound Impact Schedule
60 days
Average dressing wear time
60 days
Study Arms (2)
Allevyn Life
EXPERIMENTALFoam Dressing
Foam Dressing
OTHERStandard Care - Foam Dressing
Interventions
Foam dressing normally used by the home health agency
Eligibility Criteria
You may qualify if:
- \. The informed consent document must be read, signed, and dated by the subject or the subject's legally authorized representative before conducting any study procedures or exams. 2. Subjects sixty-five (65) years of age or older. Subjects may be of either sex and of any race.
- \. Willing and able to allow home health clinician to conduct all required study visits.
- \. The subject (or caregiver) must be able to follow instructions, including the ability to have regular contact with the home health clinician between study visits.
- \. Are covered by traditional Medicare. 6. Have a wound that is suitable for treatment with a foam dressing and can be appropriately covered by a single piece of ALLEVYN Life or the comparator dressing.
- \. At Screening, wound exudate must be moderate to heavy, as determined by the home health clinician.
- \. Target wound may be a trauma wound, chronic wound, or post-surgical wound. 9. Wound care is the primary reason for the home health clinician visits and determines the frequency of home health visits. Subjects may have other comorbidities, but these cannot be the determining factor in scheduling the frequency of the home health visits.
You may not qualify if:
- Contraindications or hypersensitivity to the use of the study dressings or their components (e.g., adhesive)
- Any wound that requires an additional covering (e.g., compression dressing, cast, etc.) over the study dressing that prevents daily visualization of the dressing under study.
- Target wound that requires daily dressing changes due to topical wound treatment (e.g., daily applications of ointments, creams, etc.)
- Target wound and dressing that cannot be visualized by the subject or subject's caregiver.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Unknown Facility
Tustin, California, 92780, United States
Unknown Facility
Wichita, Kansas, 67203, United States
Unknown Facility
McAllen, Texas, 78501, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Herbert B Slade, MD
Smith & Nephew, Inc.
- STUDY DIRECTOR
Jaime E Dickerson, PhD
Smith & Nephew, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2016
First Posted
May 18, 2016
Study Start
August 1, 2016
Primary Completion
July 1, 2017
Study Completion
October 1, 2017
Last Updated
February 9, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share